ProUroCare Medical Inc. (PUMD) Research

ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.

Market snapshot

Symbol
PUMD
Price
$0.00
Day change
0.00%
Market cap
$1.9K
P/E ratio
-0.00x
52-week range
0.0001-0.0002
Sector
Technology
Industry
Consumer Electronics

Peer companies

  • AllDigital Holdings, Inc. (ADGL)
  • Anvia Holdings Corporation (ANVV)
  • China Mulans Nano Technology Corp., Ltd. (CMNT)
  • CTX Virtual Technologies, Inc. (CTXV)
  • Cyberfort Software, Inc. (CYBF)
  • E-data Corporation (EDTA)
  • Exeo Entertainment, Inc. (EXEO)
  • Metalert, Inc. (MLRT)

Recent insider activity

  • Smith Scott E — A-Award (100000 shares) on 2013-09-20
  • Smith Scott E — J-Other (0 shares) on 2013-09-20
  • Smith Scott E — A-Award (25000 shares) on 2013-09-10
  • KAYSEN DAVID B — A-Award (25000 shares) on 2013-09-10
  • KAYSEN DAVID B — trade (0 shares) on 2013-09-09

Open ProUroCare Medical Inc. (PUMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.